BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3266842)

  • 21. Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors.
    Bodey B; Bodey B; Siegel SE
    Mod Pathol; 1995 Apr; 8(3):333-8. PubMed ID: 7617661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors.
    Saito T; Tanaka R; Yoshida S; Washiyama K; Kumanishi T
    Surg Neurol; 1988 Jun; 29(6):435-42. PubMed ID: 3259730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers.
    Miescher S; Whiteside TL; de Tribolet N; von Fliedner V
    J Neurosurg; 1988 Mar; 68(3):438-48. PubMed ID: 3257792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas.
    Kuppner MC; Hamou MF; de Tribolet N
    Cancer Res; 1988 Dec; 48(23):6926-32. PubMed ID: 3052809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
    Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
    J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
    Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
    Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor-infiltrating lymphocytes from human metastatic melanoma].
    Itoh K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2119-26. PubMed ID: 3496855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
    Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
    No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-infiltrating lymphocytes and histocompatibility antigens in primary intracranial germinomas.
    Saito T; Tanaka R; Kouno M; Washiyama K; Abe S; Kumanishi T
    J Neurosurg; 1989 Jan; 70(1):81-5. PubMed ID: 2909691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte subsets in Sjogren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence-activated cell sorter.
    Bakhshi A; Miyasaka N; Kavathas P; Daniels TE; Strand CV; Herzenberg LA; Talal N
    J Clin Lab Immunol; 1983 Feb; 10(2):63-9. PubMed ID: 6601716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
    Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
    Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cells and T-cell subsets in mycosis fungoides and parapsoriasis. A study of 18 cases with anti-human T-cell monoclonal antibodies and histochemical techniques.
    Buechner SA; Winkelmann RK; Banks PM
    Arch Dermatol; 1984 Jul; 120(7):897-905. PubMed ID: 6233942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-infiltrating lymphocytes: in vitro characterization of morphological and phenotypical changes.
    Halpern J; Islam A; Simich JP; Piver MS; Ambrus JL; Bielat KL
    Cancer Detect Prev; 1988; 13(1):1-7. PubMed ID: 3265648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cellular immunity of the patients with malignant glioma -- with special reference to the depressed cell-mediated immunity of the cerebrospinal (author's transl)].
    Uemura S; Wada S; Kodama T; Matsukado Y
    No Shinkei Geka; 1977 Aug; 5(9):931-9. PubMed ID: 303336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.